Today

Agents

Chat

Arena

Discover

More

App

Contineum Therapeutics CEO Carmine Stengone disposes of shares worth $40,029 - CTNM News | Rallies

Contineum Therapeutics CEO Carmine Stengone disposes of shares worth $40,029

CTNM•2026-08-03

CEO share sale and option exercise

Contineum Therapeutics CEO and President Carmine N. Stengone sold 2,500 Class A common shares at USD 16.01 on Aug. 3, 2026.
He acquired 2,500 Class A common shares at USD 1.01 via option exercise the same day.
Directly held Class A common shares fell to 17,217 from 19,717.
Stock options beneficially owned declined to 276,930 from 279,430.

Related News

Yum Brands CEO Christopher Lee Turner disposes of 261 common shares worth $39,974.15

YUM•2026-08-03

CIF/FOB Gulf Grain-Soybean basis values tick down as cargoes confirmed sold to China

SOYB•2026-08-03

Rocky Brands Assistant Secretary Curtis A. Loveland disposes of 3,000 common shares worth $148,860

Sources

S

Contineum Therapeutics CEO Carmine Stengone disposes of shares worth $40,029

Sec

RCKY•2026-08-03

Health In Tech corrects earnings release date to Thursday, Aug. 13

HIT•2026-08-03

AppLovin Chief Legal Officer Corina Cacovean files initial beneficial ownership statement

APP•2026-08-03